
Recently, there have been various chemical carriers and routines for treatment of infections. Plant gum nanoparticles are being used greatly for this purpose. They have several advantages over chemical drug carriers including being biodegradable, biocompatible, nontoxic, providing better tolerance to the patient, and having fewer side effects. They also do not cause allergies in humans, do not irritate the skin or eyes, and have low production costs. The use of plant gums as drug carriers is limited due to a series of disadvantages. They may have microbial contamination because of the moisture in their content. Also, in storage, their viscosity decreases due to contact with water. By green nanoparticle synthesis of these plant gums as drug carriers, the disadvantages can be limited. There are several studies showing that plant gum drug carriers can have a great combination with various drugs and nanoparticles, thus they could be extremely effective against multi-resistant bacteria and even systemic illness like cancer. These days, the need for green synthesis of medicine and drug carriers has become quite popular and it will be even more essential in the future because of emerging antibiotic-resistant bacteria and climate change.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
